In this webinar Dr. Malik Hellal and Dr. Claire Guéguen present Polyplus’ latest innovation for mRNA therapeutics. in vivo-jetRNA^®+ is a ready to use lipid-based transfection reagent specifically developed to address current limit of LNPs in targeting different organs and cell types while maintaining 100% of mRNA encapsulation, stability of liposome size at high mRNA concentration and simplicity of use and preparation (no formulation equipment is required).